Corporate Responsibility

La responsabilidad corporativa es el corazón de la misión de nuestra compañía de descubrir, desarrollar y ofrecer productos y servicios innovadores que salven y mejoren vidas.

Enfatiza nuestro compromiso de desarrollar y recompensar a nuestros empleados, proteger el ambiente y operar con las más altas normas de ética y transparencia.

Nuestro enfoque en la responsabilidad corporativa está alineado con la misión y valores de la compañía. Articula cómo vemos nuestras responsabilidades en las áreas de acceso a la salud, prácticas de negocio éticas y transparentes, operaciones ambientales sostenibles, progreso científico, bienestar de los empleados y creación de valor para nuestros accionistas.

Visita Responsabilidad Corporativa.

MSD para Madres es nuestra iniciativa de $500 millones de dólares a 10 años que aplica nuestra experiencia científica y comercial, así como nuestros recursos financieros, para ayudar a eliminar la mortalidad materna prevenible.

Trabajamos con soluciones transformadoras para fortalecer los sistemas de salud sostenibles, centrándonos en mejorar el acceso a la calidad de la atención de salud materna que las mujeres reciben en los centros de salud en el momento del parto y mejorando el acceso a anticonceptivos modernos de calidad.

Visita MSD para Madres.

El mantenimiento de este sitio es responsabilidad de Merck Sharp & Dohme Corp., una subsidiaria de Merck & Co., Inc., Kenilworth, NJ, USA.

Forward-Looking Statement

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.